-
Positive Data from Onyx - Analyst Blog
Wednesday, December 9, 2009 - 2:04pm | 482Recently, Onyx Pharmaceuticals (ONXX) came out with positive data from a phase IIb study of carfilzomib at the 51st annual meeting of the American Society of Hematology (ASH) in New Orleans. We are pleased to see that carfilzomib was found to be well-tolerated in heavily pre-treated relapsed and...
-
Fast Money Guys Share Their Dividend Play (VZ, JNJ, JPM, DUK, BP, MCD, NVS, TE, DD, DVY)
Monday, December 7, 2009 - 8:09pm | 297Dividend stocks are continuing their good run and iShares Dow Jones Select Dividend (ETF) (NYSE: DVY) gained more that 3% this month. If you prefer stocks rather then ETFs, then following picks from CNBC's Fast Money traders might be useful. Guy Adami recommends Verizon Communications (NYSE: VZ)...
-
Positive Data from Allos' Folotyn - Analyst Blog
Monday, December 7, 2009 - 5:20pm | 365Allos Therapeutics (ALTH) recently released data on Folotyn (pralatrexate injection) from the PROPEL trial, which was conducted with patients suffering from relapsed or refractory peripheral T-cell lymphoma (PTCL). In addition, the company announced preliminary results from its phase 1/2 study of...
-
DD Faces Headwinds in Prized Ag Platform
Monday, December 7, 2009 - 1:31pm | 135Analysts at Credit Suisse downgrade El DuPont de Numours & Co (NYSE: DD) from “outperform” to “neutral.” The target price for DD has been reduced from $36 to $31. According to Credit Suisse, the possibilities of DD meeting the 20% EPS growth forecast for 2009-2012 are under threat due to a...
-
Barron’s Finds Dow Chemicals (DOW) A Good Buy, Post Acquisition Of Rohm & Haas (ROH)
Monday, December 7, 2009 - 1:19pm | 82The Dow Chemical Company (NYSE: DOW) is a good buy, post its acquisition of Rohm & Haas (NYSE: ROH), noted Barron’s. Although it was pricey, the acquisition helps Dow to increase its exposure to high-margin products and could increase its profits. Dow is currently trading at $27.48 and is...
-
Fast Money Picks For December 7th (FTO, EMN, PLCE, AMAT)
Friday, December 4, 2009 - 7:19pm | 107CNBC's Fast Money Joe Terranova thinks that buying Frontier Oil Corporation (NYSE: FTO) is the best way to start a new week. Frontier Oil (FTO) jumped 1.06% on Friday. Guy Adami wants to short Eastman Chemical (NYSE: EMN), while Karen Finerman is keen on Children's Place (NASDAQ: PLCE). Children's...
-
Guy Adami Would Sell Eastman Chemical (EMN)
Friday, December 4, 2009 - 6:47pm | 61CNBC's Fast Money Guy Adami is bearish on Eastman Chemicals (NYSE: EMN). He thinks that investors that have long position in the stock should sell. Guy Adami added that Eastman Chemical (EMN) is setting up for a short. Eastman Chemical (EMN) dropped 0.60% today and closed at $59.73.
-
Micromet & Bayer Take a BiTE - Analyst Blog
Wednesday, December 2, 2009 - 5:42pm | 449Micromet (MITI), a biopharmaceutical company, is dependent on many of its collaborating partners for its product portfolio. In this respect, the company received good news with Bayer exercising its option to develop a new bispecific T-cell engager (BiTE) antibody for the treatment of solid tumors...
-
Benzinga’s Top Upgrades (LTD, BPFH, CBT, KGC, BBT, FITB, CLWR)
Tuesday, December 1, 2009 - 10:47am | 325Limited Brands, Inc. (NYSE: LTD) was today upgraded by Soleil Securities from Sell to Hold at a price target of $15.50. LTD is now trading at $17.43, 4.52% up in the morning trading hours. In the last trading session, LTD closed at $16.59. Boston Private Financial Holdings Inc (NASDAQ: BPFH)...
-
IBM to Buy Guardium - Analyst Blog
Monday, November 30, 2009 - 12:53pm | 326According to an Israeli newspaper, International Business Machines (IBM) is planning to acquire Guardium, a database security start-up for approximately $225 million. Guardium, a subsidiary of Israel's Log-On Software did not provide any details on the acquisition. The company has raised...
-
Guy Adami Is Watching Eastman Chemical (EMN)
Tuesday, November 24, 2009 - 8:10pm | 60CNBC's Fast Money Guy Adami said that he has put Eastman Chemical (NYSE: EMN) on his radar after Deutsche Bank upgraded the company from hold to buy. Deutsche Bank also raised its price target from $62 to $70. Guy Adami added that he will buy Eastman Chemical (EMN) if it closes above $61.48.
-
FMC Gets Ratings Boost From Moody's
Tuesday, November 24, 2009 - 4:38pm | 101Chemcial maker FMC (NYSE: FMC) had its senior unsecured debt upgraded by Moody's Investor Service to "Baa1" from "Baa2," on the basis sector outperformance and improved credit quality. "Baa1" is the highest level considered "lower medium grade" investment-quality debt.This comes a day after Moody'...
-
Citi retains “buy“ for DOW, raises target price
Friday, November 13, 2009 - 8:21am | 101Citi maintains its “buy“ rating for Dow Chemical Co (NYSE: DOW), while raising its earnings estimates for the company. The target price for DOW has been raised from $29 to $35. According to Citi, DOW has recovered strongly after experiencing credit crisis with the help of its heavy and rapid cost...
-
DOW Shares Increase As Rohm Acquisition Pay-Off (DOW)
Thursday, November 12, 2009 - 3:36pm | 202In a statement today, Chief Executive, Andrew Liveris said that their acquisition of Rohm and Haas has revitalized the Dow Chemical Company’s (NYSE: DOW) Portfolio and poise them for good earnings for the next two years. The Rohm assets should also contribute positively to their sales, boosting it...
-
Top 5 S&P Leaders (AMD, JDSU, DOW, GT, NDAQ)
Thursday, November 12, 2009 - 1:50pm | 187Advanced Micro Devices Inc (NYSE: AMD) shares have risen by 22.18% to $6.50 in the morning trade. AMD and rival Intel (NASDAQ: INTC) have agreed to a $1.25 billion-settlement, settling their antitrust litigation and patent cross-license disputes. JDS Uniphase Corp (NASDAQ: JDSU) shares have risen...